Select Page

The Infinium Global Research analyzes the Biologics Market over the period of 2020 to 2026. This report also provides detailed qualitative and quantitative analyses of the market dynamics, market size and future trends in global biologics market. It will help a lot of decision makers to develop strategies and find new opportunities in the global markets of biologics. The report covers market changing aspects including drivers, restraints, opportunities, and trends expected to encouragement the expansion of the biologics market during the period. The global biologics market is projected to grow at a CAGR of 10.7% over the forecast period of 2020-2026.

"We are Now Including the Impact Analysis of the COVID-19 on this Premium Report and the Forecast Period of this Report shall be Revised to 2020-2026." 

The Section on the Impact of COVID-19 on this Market is Included in the Report for Free. To Know More Request Sample of this Report:   

Biologics, are pharmaceutical compounds extracted from biological sources, the structure of which are highly complex. Biologics are mainly divided into two forms including monoclonal antibodies and receptor modulators. Glycocarbohydrates, fatty acids, and amino acids are the additional moieties in these compounds. These additional moieties help to maintain the triple and quadruple structures. The high -molecular weight of the compounds combined with special formulations influences their pharmacokinetic and pharmacodynamic properties as well as their biological activities. 

Prevalence of Cancer and Autoimmune Disease Facilitating the Market Growth

As per the World Health Organization, cancer is the leading cause of death globally and responsible for 9.6 million deaths in 2018. The impact of cancer is affecting economically and is increasing. In 2010, the economic cost of cancer was estimated at approximately US$1.16 trillion. According to the American Autoimmune Related Diseases Association, autoimmune diseases are a major health problem affecting individuals and families. The devastating effects of immunosuppressant treatments are long-term side effects. Biologics are considered immunosuppressing as they work on different immune system pathways to curtail the inflammation. The market is expected to witness exponential growth by the end of 2020.

North America and Europe continue to dominate the global biological drugs market due to technological advancements, favorable regulatory policies, and increasing awareness about the biologics.

Leading Players Concentrating on Research and Development

Roche, one of the leading players in biologics drugs, has several innovative cancer drugs including Herceptin, Avastin, MabThera/ Rituxan, Xeloda, and Tarceva that offer clear survival benefits in different types of cancer. Each drug has its unique mechanism of action that halts tumor growth. In February 2019, another company Eli lily voiced its support of the FDA’s proposed approach to the transition of products that are currently addressed under the Federal Food, Drug and Cosmetic Act and has also called on the FDA to clarify about the introduction of ‘second versions’ of their innovator biologics.

Enquire Here Get Customization & Check Discount for Report @ 

Major Highlights of this Premium Report


  • Report Description
  • Research Methods
  • Research Approaches

Executive Summary

  • Biologics Market Highlights
  • Biologics Market Projection
  • Biologics Market Regional Highlights

Global Biologics Market Overview

  • Introduction
  • Market Dynamics
  • Analysis of COVID-19 impact on the Biologics Market
  • Porter's Five Forces Analysis
  • IGR-Growth Matrix Analysis
  • Value Chain Analysis of Biologics Market

Biologics Market Macro Indicator Analysis

Global Biologics Market by Product

  • Monoclonal Antibodies
  • Vaccines
  • Recombinant Proteins
  • Others (Antisense, RNAi & Molecular Therapy Products)

Global Biologics Market by Therapy Areas

  • Autoimmune
  • Antidiabetics
  • Oncologics

Global Biologics Market by Region 2020-2026

  • North America
  • Europe
  • Asia-Pacific
  • RoW

Company Profiles and Competitive Landscape

  • F Hoffman La Roche
  • Eli Lilly & Company
  • Samsung Biologics
  • Celltrion Inc.
  • Amgen Inc.
  • Abbvie Inc.
  • Sanofi S.A.
  • Pfizer Inc.
  • Novo Nordisk A/S
  • Johnson & Johnson Services Inc.

Browse Complete Report@

Reasons to Buy this Report: 

  • Comprehensive analysis of global as well as regional markets of the biologics.
  • Complete coverage of all the product type and applications segments to analyze the trends, developments, and forecast of market size up to 2026. 
  • Comprehensive analysis of the companies operating in this market. The company profile includes analysis of product portfolio, revenue, SWOT analysis and the latest developments of the company.  
  • Infinium Global Research- Growth Matrix presents an analysis of the product segments and geographies that market players should focus to invest, consolidate, expand and/or diversify.